Basic Information
| LncRNA/CircRNA Name | circ_EPB41L2 |
| Synonyms | |
| Region | |
| Ensemble | |
| Refseq |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | lung adenocarcinoma |
| ICD-0-3 | C34 |
| Methods | qPCR, Western blotting |
| Sample | lung adenocarcinoma tissues and cell lines |
| Expression Pattern | down-regulated |
| Function Description | Circ_EPB41L2 and CDH4 were down-regulated in LUAD tissues and cell lines. Overexpressed circ_EPB41L2 or CDH4 acted as a suppressor in the LUAD cell proliferation, invasion and migration in vitro. |
| Pubmed ID | 32329852 |
| Year | 2020 |
| Title | CircRNA EPB41L2 inhibits tumorigenicity of lung adenocarcinoma through regulating CDH4 by miR-211-5p |
External Links
| Links for circ_EPB41L2 | GenBank HGNC NONCODE |
| Links for lung adenocarcinoma | OMIM COSMIC |